Actavis acquires remaining stake in Turkish pharmaceutical company Fako
Advertisement
Actavis Group announced that it has acquired the remaining 11% stake in the Turkish generic pharmaceuticals company Fako for US$20.4 million. Fako now becomes a wholly-owned subsidiary of the Actavis Group.
Actavis acquired an 89% stake in Fako in December 2003 for an initial purchase price of US$63 million. In addition, Actavis agreed to provide Fako with up to US$15 million to assist its funding requirements.
Fako is Turkey's fifth-largest generic pharmaceutical company, specialising in the development, production and sales of pharmaceuticals. It has a total workforce of around 1,200 employees. Along with its headquarters in Istanbul, the company has 10 sales offices throughout Turkey. Fako also develops and produces active pharmaceutical ingredients.